Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

New molecules can prevent cell death in hair follicles.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Long-term use of seizure medications can disrupt calcium metabolism, but this can be treated with vitamin D or UV light and does not affect seizure control.

Overexpression of COX-2 in mice skin causes abnormal skin and hair development.

A woman developed lupus after taking hydroxyurea for two years.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Nicastrin deficiency may cause skin cell damage and pigmentation disorders in humans, similar to effects seen in fish.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

New compounds may help treat prostate issues without affecting androgen receptors.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.